Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
11/2008
11/26/2008EP1370572B1 Mitochondrial membrane permeabilization by hiv-1 vpr and methods of screening
11/26/2008EP0735893B1 Pan dr-binding peptides for enhancement of the immune response
11/26/2008CN101313068A Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications
11/26/2008CN101313063A Cancer-rejection antigen peptide derived from glypican-3 (GPC3) for use in HLA-A2-positive patient and pharmaceutical comprising the antigen
11/26/2008CN101311190A Antigen epitope for exciting protective immunity against tubercle bacillus of human body and uses thereof
11/26/2008CN101311189A Antigen epitope for exciting protective immunity against tubercle bacillus of human body and uses thereof
11/26/2008CN101311188A Small molecule peptides inhibitor of human heparinase
11/26/2008CN100436477C Cyclic peptide containing arginine, glycine, asparagicacid-sequence and active target liposome
11/26/2008CN100435775C Use of 3-position cyclosporin derivatives for hair growth
11/25/2008US7456276 Peptide purification by means of metal ion affinity chromatography
11/25/2008US7456253 Growth hormone releasing peptides
11/25/2008US7456252 Synthetic peptides to treat an autoimmune demylinating disease e.g., multiple sclerosis; an amino acid sequence having two tyrosine residues and a lysine complex with the myelin basic protein to modulate an immune response
11/25/2008US7455984 Immunoreactive and immunotherapeutic molecules
11/20/2008WO2008141190A1 Heterologous production of capreomycin and generation of new capreomycin derivatives through metabolic engineering
11/20/2008WO2008140834A2 Novel antimicrobial peptides
11/20/2008WO2008140828A1 Inhibitors of acetyl-coa carboxylase for treatment of neuronal hypometabolism
11/20/2008WO2008140602A2 USE OF ANTAGONISTS OF THE INTERACTION BETWEEN HIV GP120 AND α4β7 INTEGRIN
11/20/2008WO2008139986A1 New cyclic peptide compounds
11/20/2008WO2008109433A3 Anti-angiogenic peptides
11/20/2008WO2008107448A3 Process for the manufacture of a composite material
11/20/2008WO2008098693A3 Convergent synthesis of glp-1
11/20/2008WO2008097854A3 Method and substances for treating hpv infection
11/20/2008WO2008085828A3 Peptide modulators of angiogenesis and use thereof
11/20/2008US20080289065 Peptide Aptamers That Bind to the Rep Proteins of Ssdna Viruses
11/20/2008US20080287653 Method for producing inhibitors and inhibitors formed therefrom
11/20/2008US20080287652 Antagonists Against Interaction of Pf4 and Rantes
11/20/2008US20080287650 High purity peptides
11/20/2008US20080287367 Non-Toxic Biofilm Inhibitor
11/20/2008US20080287362 Compositions and Methods for the Detection of Trypanosoma Cruzi Infection
11/20/2008US20080287352 Anti-Histone H1 Monoclonal Antibody and Hybridoma for the Production Thereof
11/20/2008US20080287347 Novel Lipopeptides as Antibacterial Agents
11/20/2008US20080287346 Bioactive peptides
11/20/2008US20080287342 Compositions Comprising Modified Collagen and Uses Therefor
11/20/2008US20080286814 Biomarkers for Detecting Cancer
11/20/2008US20080286799 Methods of and kits and compositions for diagnosing colorectal tumors...
11/20/2008US20080286760 Means and Methods for the Determination of Camp In Vitro and In Vivo
11/20/2008US20080286293 Promiscuous pap cd4 t cell epitopes
11/20/2008US20080286276 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
11/20/2008US20080286210 Novel antimicrobial peptides
11/20/2008CA2685380A1 Inhibitors of acetyl-coa carboxylase for treatment of neuronal hypometabolism
11/20/2008CA2684557A1 New cyclic peptide compounds
11/19/2008EP1992639A1 Peptide vaccine for inducing production of anti-amyloid- -peptide antibody
11/19/2008EP1992611A1 Novel isodipeptide
11/19/2008EP1991586A1 Chimeric constructs between cancer-homing peptides and cell-penetrating peptides coupled to anticancer drugs and/or diagnostic agent/agents
11/19/2008EP1991562A2 Cancer imaging and treatment
11/19/2008EP1991561A2 Branched multimeric peptides for tumor diagnosis and therapy
11/19/2008EP1991560A1 Peptide having cell membrane penetrating activity
11/19/2008EP1453539B1 Immunotherapeutic methods and systems
11/19/2008EP0888120B1 Immunogenic hla binding peptide and its uses to treat hiv infection
11/19/2008CN101307106A Endothelial cell proliferation inhibitor and method of use
11/19/2008CN101307095A T-cell epitope peptide
11/19/2008CN101307094A Novel nuclear factor ¿Ckappa B p65 subunit antagonizing polypeptide
11/19/2008CN100434438C Preparation method of CYP1A2 polypeptide and antihuman CYP1A2 polypeptide antibody
11/19/2008CN100434437C Biological active peptides comprising isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonine
11/18/2008US7452965 nine amino acid, disulfide-constrained peptide that selectively bound and was internalized into colon cancer cells; exhibit decreased or a substantially nonexistent immunogenicity in an in vivo system
11/18/2008US7452679 Hybridization; phage display; spectroscopy
11/18/2008US7452551 Administering to the patient a contrast agent comprising, in an aqueous carrier, targeted vesicles formulated from a lipid or polymer, a perfluorocarbon gas, a targeting ligand, scanning the patient using ultrasound to obtain an image
11/18/2008CA2288234C Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/18/2008CA2221517C Synthesis of n-substituted oligomers
11/18/2008CA2157975C Recombinant mersacidin and a method for production
11/18/2008CA2124329C Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
11/13/2008WO2008137720A2 Peptide analogs that are potent and selective for human neurotensin receptor subtype 2
11/13/2008WO2008136850A2 Cobalamin conjugates useful as imaging and therapeutic agents
11/13/2008WO2008135756A1 Peptide standards
11/13/2008WO2008083678A3 Pharmaceutically active compounds
11/13/2008WO2008083326A3 Targeting of ews-fli1 as anti-tumor therapy
11/13/2008WO2008052933A3 Prevention of aggregation of immunoglobulin light or heavy chains
11/13/2008WO2008028688A3 Compounds and methods for 18f labeled agents
11/13/2008WO2008014238A3 Dimeric iap inhibitors
11/13/2008US20080280834 Compounds and methods for inhibiting apoptosis
11/13/2008US20080280833 amino acid motif GAAG; polypeptide that inhibits cell migration, cell adhesion, cell proliferation and/or cell differentiation; anticancer; adenocarcinoma, leukemia, lymphoma, or myeloma; inhibitor of chemotaxis
11/13/2008US20080280827 peptide(s) capable of inhibiting the TGF- beta activation reaction. The present invention provides a peptide consisting of 11 to 50 amino acid residues, which comprises an amino acid sequence Gln-Ile-Leu-Ser-X1-X2-X3-X4-Ala-Ser-Pro (SEQ ID NO: 1) wherein each of X1 to X4 independently represents
11/13/2008US20080280822 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer
11/13/2008US20080280820 Novel Peptides for Use in the Treatment of Obesity
11/13/2008US20080280818 Glycosylation of peptides via o-linked glycosylation sequences
11/13/2008US20080280781 Methods and Compositions for Increasing Membrane Permeability
11/13/2008US20080280358 Synthetic Peptides that Cause F-Actin Bundling and Block Actin Depolymerization
11/13/2008US20080280326 Peptide comprising luteinizing hormone releasing hormone activity for use as tool in designing treatments for brain disorders; pesticides
11/13/2008US20080280308 G protein coupled receptor signaling modulation
11/13/2008US20080279924 HLA class I A2 tumor associated antigen peptides and vaccine compositions
11/13/2008US20080279908 Hydroxyapatite-Binding Peptides for Bone Growth and Inhibition
11/13/2008US20080279878 Compositions of Hsp60 Peptides and Viral Antigens for Vaccination and Diagnosis
11/13/2008US20080279871 Immunogenic composition
11/13/2008US20080279771 Novel Imaging Agents for Cancer
11/13/2008US20080279765 targeting the mannose-6-phosphate (M6P) receptor suitable for the non-invasive visualization
11/13/2008CA2686381A1 Peptide standards
11/12/2008EP1990058A1 Aglyco products and their use for inhibiting infection by influenza virus, and useof hexosamine precursor in schizophrenia treatment
11/12/2008EP1990057A1 Beta-secretase substrates and uses thereof
11/12/2008EP1989324A1 Pcr hot start by magnesium sequestration
11/12/2008EP1523582B1 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same
11/12/2008EP1478659B1 Biologically active peptides
11/12/2008EP1469010B1 Transcription regulatory gene and peptide
11/12/2008EP1436321B9 Synthesis of cyclosporin analogs
11/12/2008EP1432729B1 Peyers's patch and/or m-cell targeting ligands
11/12/2008EP1421387B1 Cellular immunity test with peptides fixed on a solid support
11/12/2008EP1395275B1 Beta-secretase substrate and uses thereof
11/12/2008EP0701569B1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
11/12/2008CN101305019A New cyclic peptide compounds
11/12/2008CN101305018A Process and intermediates for the synthesis of caspofungin
11/12/2008CN101302247A Method for extracting nosipeptide crude product
1 ... 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 ... 423